MedTrace Logo

Control of Assistive Devices Via Brain-Computer Interface Technology

NCT06710626 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2025-06-05

No results posted yet for this study

Summary

The CONVOY Study is a clinical trial designed to explore the feasibility of participants from the PRIME Study (NCT06429735) using the N1 Implant to control various assistive devices. The main goal is to determine whether participants can successfully modulate their brain activity to control devices, such as an Assistive Robotic Arm (ARA). This study will assess the effectiveness, consistency, and safety of neural control using the ARA and other assistive devices.

Conditions

  • Tetraplegia/Tetraparesis
  • Amyotrophic Lateral Sclerosis (ALS)
  • Quadriplegia
  • Spinal Cord Injury (SCI)
  • Spinal Cord Injury Cervical

Interventions

DEVICE

Assistive Robotic Arm

The intervention involves using the N1 Implant, a wireless brain-computer interface (BCI), to enable participants to control the Assistive Robotic Arm through neural signals.

Sponsors & Collaborators

  • Neuralink Corp

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-25
Primary Completion
2031-05-25
Completion
2031-05-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06710626 on ClinicalTrials.gov